JOHN LARSEN: Open Payments
NPI 1538422118 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37,581 in 167 payments from 15 companies in 2025. Trend: 2023 $2,881 · 2024 $4,543 · 2025 $37,581
Speaker / faculty: $18,398Consulting: $9,992Travel & lodging: $6,152Food & beverage: $3,039
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 92 | $30,120 |
| AstraZeneca Pharmaceuticals LP | 24 | $3,175 |
| GENZYME CORPORATION | 8 | $1,637 |
| Regeneron Pharmaceuticals, Inc. | 2 | $1,344 |
| GlaxoSmithKline, LLC. | 27 | $575 |
| Verona Pharma, Inc. | 5 | $209 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Lilly USA, LLC | 1 | $115 |
| Actelion Pharmaceuticals US, Inc. | 1 | $85 |
| ABBVIE INC. | 1 | $23 |
Products named: DUPIXENT, BREZTRI, FASENRA, NUCALA, AIRSUPRA, Ohtuvayre, TRELEGY ELLIPTA, Adempas.
Industry payments across NV — which companies pay providers there.
